Recall: D-0419-2020

Class II - Potentially Harmful

Class IIClassification

2019-07-02Initiated

CompletedStatus

Altaire Pharmaceuticals, Inc.Firm

Product

Altaire Ciprofloxacin Ophthalmic Solution, USP, 0.3%, Rx only 2.5 mL, Altaire Pharmaceuticals, Inc Aquebogue, NY 11931 NDC 59390-217-02

Reason

Lack of Assurance of Sterility

Distribution

U.S.A. Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.